The QbD Group supports companies worldwide in the life sciences throughout the entire product lifecycle, from idea to patient.

The QbD Group aspires to be the reference service partner to tackle complex challenges.

The core of the business is data-driven.

Bart Van Acker, Founder & CEO

Objective 2025: The QbD Group’s ambition is to have a presence in 8 European countries with 1500 colleagues, set a footprint in the US and become the reference in Latin America. As we grow, we will add more services and solutions to our value chain. We aim to be best in ATMP, IVD, Medical Devices & Digital Health and will continue to invest in these domains.



Extra mile

Getting things done

Welcome to our 7 divisions


Regulatory Affairs

We help our clients in their journey throughout the entire drug and medical device regulatory lifecycle.


We are an expert clinical solutions provider specialized in medical devices and biotech, offering global CRO services and consultancy.

Qualification & Validation

We guarantee that products meet quality demands and comply with regulations through the qualification and validation of your equipment, facilities, and process support.

Quality Assurance

We offer the full range of QA services necessary to get your product to market in a safe and compliant way, including auditing from certified auditors, setting up your QMS, and all QP activities.

Lab Services

Our lab services division consists of a GMP laboratory that offers analytical services for testing pharmaceutical raw materials, excipients, and release testing of finished products.

Software Solutions & Services

Our solutions include a cloud-based and pre-validated QMS built for the life sciences, as well as eIFU services which enable IVD and MD manufacturers to digitalize paper Instructions For Use.

Our range of services include Computer System Validation and Digital Health services.

Business & Communications

We help you launch your product to market by providing marketing and communication services, business development support and sales strategy.